Nuvectis Pharma, Inc. - Common Stock — Cash Flow (NASDAQ:NVCT) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -13.56 M-15.95 M-12.25 M-16.01 M -18.35 M Cash from investing activities —000 0 Cash from financing activities 27.81 M15.09 M11.65 M29.11 M 13.61 M Free cash flow -13.56 M-15.95 M-12.25 M-16.01 M -18.35 M

News

Wall Street Analysts Think Nuvectis Pharma (NVCT) Could Surge 57%: Read This Before Placing a Bet

Wall Street Analysts Believe Nuvectis Pharma (NVCT) Could Rally 62.5%: Here's is How to Trade

Nuvectis initiates phase 1b trial combining NXP900 with osimertinib

Nuvectis Pharma stock rating reiterated at Buy by H.C. Wainwright

H.C. Wainwright reiterates Buy rating on Nuvectis Pharma stock at $10 target

Nuvectis Pharma adds former Intra-Cellular exec to board of directors

Nuvectis initiates phase 1b program for cancer drug NXP900

Nuvectis (NVCT) Q2 Loss Widens 43%

Nuvectis Pharma stock price target lowered to $10 at H.C. Wainwright

Nuvectis halts NXP800 development for ovarian cancer, shifts focus

Nuvectis reports positive drug interaction study for cancer drug NXP900

Friday’s Insider Activity: Top Buys and Sells in US Stocks